Mechanistic Insights into Succinic Acid as an Adjuvant for Ciprofloxacin in Treating Pseudomonas aeruginosa Growing Within Cystic Fibrosis Airway Mucus
2024

Using Succinic Acid to Help Antibiotics Treat Pseudomonas aeruginosa in Cystic Fibrosis

publication 10 minutes Evidence: moderate

Author Information

Author(s): Monteiro Rosana, Silva Eduarda, Pereira Maria Olivia, Sousa Ana Margarida

Primary Institution: University of Minho

Hypothesis

Can succinic acid enhance the effectiveness of ciprofloxacin against Pseudomonas aeruginosa in cystic fibrosis mucus?

Conclusion

Succinic acid can improve the effectiveness of ciprofloxacin against Pseudomonas aeruginosa, especially in the early stages of bacterial growth.

Supporting Evidence

  • Succinic acid showed strong antibacterial properties against Pseudomonas aeruginosa in early growth stages.
  • Combining succinic acid with ciprofloxacin led to significant reductions in bacterial counts.
  • Succinic acid's effectiveness decreased at later growth stages and in dense CF mucus.

Takeaway

This study found that adding succinic acid to an antibiotic can help fight off a tough germ that makes people with cystic fibrosis sick.

Methodology

The study used time-kill assays and biofilm experiments to assess the effects of succinic acid and ciprofloxacin on Pseudomonas aeruginosa.

Limitations

The study's findings may not fully replicate the complex conditions in cystic fibrosis lungs, and the efficacy of succinic acid was reduced in dense mucus environments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/microorganisms12122538

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication